Commonwealth Scientific and Industrial Research Organisation

Medical Research Council

Cambridge Antibody Technology Limited

Other

Bayer Cropscience Nv

Grains Research and Development Corporation

Bayer Bioscience N.v.

Peter Michael Waterhouse

Ming-Bo Wang

Gregory Paul Winter

Andrew David Griffiths

Kevin Stuart Johnson

Surinder Pal Singh

Jeroen Van Rie

Susan V Wesley

Christopher A Helliwell

Michael Wayne Graham

Andrew John Smith

Craig Christopher Wood

Fatima Naim

Ahuva Nissim

Samuel Cameron Williams

Robert Norman Rice

Philip John Larkin

Steven Whyard

Andrew John Hammond Smith

Paul Wing Gay Chu

Rafiqul Islam Khan

Jerry Stuart Marshall

William Clark Taylor

Paul Konrad Keese

Petra Christina Boevink

Brian Peter Surin

Neil A Smith

Ming Bo Wang

Chris Helliwell

Christopher Andrew Helliwell

Mingbo Wang

Michael Graham

The present invention relates to genetically modified cells that are capable of optimal transgene expression by co-expressing a silencing suppressor whilst at the same time are also capable of silencing a gene, such as a naturally occurring gene of the cell. The present invention also relates to methods of producing the modified cells, as well as relates to processes for obtaining a genetically modified cell with a desired property.

Simultaneous gene silencing and suppressing gene silencing in ihe same cell

Simultaneous gene silencing and suppressing gene silencing in the same cell

Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eukaryotic cells by providing aberrant, preferably unpolyadenylated, target-specific RNA to the nucleus of the host cell. Preferably, the unpolyadenylated, target-specific RNA is provided by transcription of a chimeric gene comprising a promoter and a DNA region encoding the target-specific RNA.

Methods and means for obtaining modified phenotypes

The present invention relates generally to a method of modifying gene expression and to synthetic genes for modifying endogenous gene expression in a cell, tissue or organ of a transgenic organism, in particular a transgenic animal or plant. More particularly, the present invention utilizes recombinant DNA technology to post-transcriptionally modify or modulate the expression of a target gene in a cell, tissue organ or whole organism, thereby producing novel phenotypes. Novel synthetic genes and genetic constructs which are capable of repressing delaying or otherwise reducing the expression of an endogenous gene or target gene in an organism when introduced thereto are also provided.

Control of gene expression

Provided are methods and means to obtain improved gene silencing of target nucleic acids whereby at least two inhibitory RNA molecules are provided which are targeted to the same nucleic acid, but which are processed into short interfering RNA molecules through different processing pathways. Also provided are methods and means to obtain improved gene silencing of target nucleic acids whereby at least two inhibitory RNA molecules are provided which are targeted to different nucleic acids, but which are processed into short interfering RNA molecules through different processing pathways.

Gene silencing methods

Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eucaryotic cells, particularly in plant cells, by introducing chimeric genes encoding sense and antisense RNA molecules directed towards the target nucleic acid, which are capable of forming a double stranded RNA region by base-pairing between the regions with sense and antisense nucleotide sequence or by introducing the RNA molecules themselves. Preferably, the RNA molecules comprises simultaneously both sense and antisense nucleotide sequence.

Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eukaryotic cells, particularly in plant cells, by providing aberrant, preferably unpolyadenylated, target-specific RNA to the nucleus of the host cell. Preferably, the unpolyadenylated target-specific RNA is provided by transcription of a chimeric gene comprising a promoter, a DNA region encoding the target-specific RNA, a self-splicing ribozyme and a DNA region involved in 3' end formation and polyadenylation.

Methods and means are provided for producing chimeric nucleic acid constructs capable of producing dsRNA for silencing target nucleic acid sequences of interest using recombinational cloning.

Methods and means for producing efficient silencing construct using recombinational cloning

Methods and vectors and kits are provided for producing chimeric nucleic acid constructs capable of producing dsRNA for silencing target nucleic acid sequences of interest using recombinational cloning.

Methods and means for efficiently downregulating the expression of any gene of interest in eukaryotic cells and organisms are provided. To this end, the invention provides modified antisense and sense RNA molecules, chimeric genes encoding such modified antisense or sense RNA molecules and eukaryotic organisms such as plants, animals or fungi, yeast or molds, comprising the modified antisense and/or sense RNA molecules or the encoding chimeric genes.

Modified gene-silencing RNA and uses thereof

Growing community of inventors

Canberra, Australia

Peter Michael Waterhouse